SEC Form 4 · accession 0001209191-18-015028

STERIS plc · STE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Feb 28, 2018

Accepted (ET)

Mar 1, 2018 · 4:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001624899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Ordinary Shares, 10 pence par value	Feb 28, 2018	M	2,744	$34.17	A	2,744	D
Ordinary Shares, 10 pence par value^F1	Feb 28, 2018	S	2,744	$91.94	D	0	D
Ordinary Shares,10 pence par value^F2	holding	—	—		—	41,570	I	See Footnote Below

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Director Stock Option (right to buy)^F3	$34.17	Feb 28, 2018	M	2,744	D	—	Jul 31, 2018	Ordinary Shares	2,744	0	D

F1Price reflects a weighted average sale price for multiple transactions ranging from $91.80 to $92.15 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price
F2These Ordinary Shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,230 shares that had been directly held were transferred to the trust on December 1, 2017.
F3This option to purchase 2,744 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 2,744 STERIS Corporation common shares for $34.17 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.